MK2 inhibitors (Celgene)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMK2 inhibitors (Celgene)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMAP kinase-activated protein kinase 2 inhibitors
TargetsMAP kinase-activated protein kinase 2
Therapy Area/IndicationsInflammationAutoimmune DiseasesArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesCelgene Corp
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsInflammationArthritis

Other Information

ATC CodeN/A
Related LinksN/A